Evaluation of the ChronoS Therapy on the Severity of Sleep Disturbances Among Patients With Mood Disorders: A Within-subjects Study
CRHONOS
1 other identifier
interventional
67
1 country
1
Brief Summary
A new psychotherapy has been developed within the Psychiatry, Sleep and Chronobiology Reference Center (ChronoS) since January 2022.Results have shown relevant clinical interest on insomnia symptoms, as well on mood, anxiety and hypervigilance, according to the observation of the center's team (nurses, psychologists, psychiatrists and somnologist) In order to evaluate the effectiveness of this psychotherapy, the investigators would like to carry a multimodal approach on the severity of insomnia in patients with mood disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedFirst Submitted
Initial submission to the registry
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedFirst Posted
Study publicly available on registry
September 18, 2025
CompletedSeptember 18, 2025
September 1, 2025
1.7 years
January 31, 2025
September 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia Severity Index (ISI)
brief self report questionnaire to assess the severity of insomnia cases
Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy
Secondary Outcomes (19)
Seasonal Pattern Assessment Questionnaire (SPAQ)
Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy
Morningness-Eveningness Questionnaire (MEQ)
Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy
The Berlin Questionnaire
Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy
Pittsburgh Sleep Quality Index
Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy
The Epworth Sleepiness Scale (ESS)
Baseline visit : at participants' inclusion Visit 1: alongside 1st session of the therapy Visit 2: after the 4th session of the therapy Visit 3: after the last session (8th) of the therapy Visit 4 : 3 months after the end of the therapy
- +14 more secondary outcomes
Study Arms (2)
Bipolar disorder
EXPERIMENTALBipolar disorder is defined by the DSM-5 as the experience of episodes of depression or anhedonia (i.e., a lack of interest or pleasure in activities) and at least four additional symptoms: decreased energy; psychomotor slowing or psychomotor restlessness; changes in appetite and weight; sleep disturbance (from insomnia to hypersomnia); difficulty concentrating and/or inability to make everyday decisions; feelings of worthlessness and/or excessive guilt; and suicidal ideation and attempts.
Unipolar disorder
EXPERIMENTALUnipolar disorder is defined by the DSM-5 as the experience of 5 or more of the following symptoms, at least once per day, and for a period that's longer than 2 weeks: * Sadness or irritability, lasting most of the day * Loss of interest in the majority of activities that were enjoyable before * Change in appetite, or sudden weight loss/gain * Difficulty falling asleep, or wanting to sleep more than before * Feelings of restlessness * Lack of energy and increased tiredness * Feelings of worthlessness or guilt, often linking to things that normally wouldn't have this kind of effect * Difficulty concentrating, making decisions and thinking * Suicidal or self-harming thoughts
Interventions
Session 1 : Introduction and awareness of the sleep-wake link Session 2 : Awareness of day/night habits and behaviors Session 3 : Awareness of sleep/wake rhythms and sleepiness signals Session 4 : Awareness of the night/bed/sleep association Session 5 : Awareness of emotions and thoughts related to sleep Session 6 : Awareness of possible alternatives Session 7 : Awareness of one's relationship to sleep Session 8 : Awareness of future benefits
Eligibility Criteria
You may qualify if:
- Aged over 18 years old
- Diagnosed with
- A mood disorder (bipolar or unipolar) recognized in the DSM-5
- Chronic insomnia disorder recognized in the DSM-5
- Must have obtained a score ≥ 8 on the ISI scale evaluated by the clinician, that indicates at least an insomnia of mild intensity
You may not qualify if:
- Patients aged under 18 years old
- Patients with psychotic disorder
- Patients who have previously undergone CBT insomnia or other targeted cognitive behavioral therapy
- Patients under guardianship, curatorship or protection of the court
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre CHRONOS
Paris, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pierre-Alexis GEOFFROY, Professor of psychiatry
GHU Paris Psychiatrie et Neurosciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2025
First Posted
September 18, 2025
Study Start
April 30, 2023
Primary Completion
December 30, 2024
Study Completion
March 30, 2025
Last Updated
September 18, 2025
Record last verified: 2025-09